Suppr超能文献

通过 Vβ T 细胞受体表达定义的 CD4(+) T 细胞与人类利什曼病的免疫调节谱和病变大小相关。

CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

机构信息

Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

Clin Exp Immunol. 2011 Sep;165(3):338-51. doi: 10.1111/j.1365-2249.2011.04430.x. Epub 2011 Jul 4.

Abstract

Leishmaniasis is caused by infection with the protozoan parasite, Leishmania, that parasitizes human cells, and the cellular immune response is essential for controlling infection. In order to measure the host T cell response to Leishmania infection, we have measured the expansion, activation state and functional potential of specific T cells as identified by their T cell receptor Vβ region expression. In a group of cutaneous leishmaniasis (CL) patients, we evaluated these characteristics in nine different T cell subpopulations as identified by their Vβ region expression, before and after specific Leishmania antigen stimulation. Our results show: (1) an increase in CD4(+) T cells expressing Vβ 5·2 and Vβ 24 in CL compared to controls; (2) a Leishmania antigen-induced increase in CD4(+) T cells expressing Vβ 5·2, 11, 12 and 17; (3) a profile of previous activation of CD4(+) Vβ 5·2-, 11- and 24-positive T cells, with higher expression of CD45RO, HLA-DR, interferon-γ, tumour necrosis factor-α and interleukin-10 compared to other Vβ-expressing subpopulations; (4) a positive correlation between higher frequencies of CD4(+) Vβ5·2(+) T cells and larger lesions; and (5) biased homing of CD4(+) T cells expressing Vβ 5·2 to the lesion site. Given that CL disease involves a level of pathology (ulcerated lesions) and is often followed by long-lived protection and cure, the identification of specific subpopulations active in this form of disease could allow for the discovery of immunodominant Leishmania antigens important for triggering efficient host responses against the parasite, or identify cell populations most involved in pathology.

摘要

利什曼病是由原生动物寄生虫利什曼原虫感染引起的,寄生虫寄生在人体细胞中,细胞免疫反应对于控制感染至关重要。为了测量宿主对利什曼原虫感染的 T 细胞反应,我们测量了 T 细胞受体 Vβ 区表达鉴定的特定 T 细胞的扩增、激活状态和功能潜力。在一组皮肤利什曼病 (CL) 患者中,我们在特定利什曼原虫抗原刺激前后,评估了这九种不同的 T 细胞亚群的这些特征,这些 T 细胞亚群是根据其 Vβ 区的表达来确定的。我们的结果表明:(1) 与对照组相比,CL 患者中表达 Vβ 5·2 和 Vβ 24 的 CD4+T 细胞增加;(2) 利什曼原虫抗原诱导 CD4+T 细胞表达 Vβ 5·2、11、12 和 17;(3) CD4+Vβ 5·2-、11-和 24-阳性 T 细胞的前激活特征,与其他 Vβ 表达亚群相比,CD45RO、HLA-DR、干扰素-γ、肿瘤坏死因子-α和白细胞介素-10 的表达更高;(4) CD4+Vβ5·2+T 细胞的频率越高,病变越大;(5) 表达 Vβ 5·2 的 CD4+T 细胞向病变部位的偏向归巢。鉴于 CL 疾病涉及一定程度的病理学(溃疡性病变),并且经常伴随着长期的保护和治愈,识别在这种疾病形式中活跃的特定亚群可以发现对寄生虫触发有效宿主反应重要的免疫优势利什曼原虫抗原,或识别与病理学最相关的细胞群体。

相似文献

3
T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions.
J Invest Dermatol. 2010 May;130(5):1329-36. doi: 10.1038/jid.2009.428. Epub 2010 Jan 28.
5
CD4 T cell activation by B cells in human Leishmania (Viannia) infection.
BMC Infect Dis. 2014 Feb 25;14:108. doi: 10.1186/1471-2334-14-108.

引用本文的文献

2
T-cell receptor variable region usage in Chagas disease: A systematic review of experimental and human studies.
PLoS Negl Trop Dis. 2022 Sep 15;16(9):e0010546. doi: 10.1371/journal.pntd.0010546. eCollection 2022 Sep.
4
Infection of Human Monocytes with Strains Induces a Downmodulated Response when Compared with Infection with .
Front Immunol. 2018 Jan 8;8:1896. doi: 10.3389/fimmu.2017.01896. eCollection 2017.
5
Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis.
Am J Trop Med Hyg. 2017 Mar;96(3):645-652. doi: 10.4269/ajtmh.16-0539. Epub 2017 Apr 6.
8
T-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil.
Mem Inst Oswaldo Cruz. 2015 Aug;110(5):596-605. doi: 10.1590/0074-02760150039. Epub 2015 Jun 24.
9
Proteome profiling of human cutaneous leishmaniasis lesion.
J Invest Dermatol. 2015 Feb;135(2):400-410. doi: 10.1038/jid.2014.396. Epub 2014 Sep 10.
10
Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.
J Infect Dis. 2015 Jan 15;211(2):274-82. doi: 10.1093/infdis/jiu439. Epub 2014 Aug 19.

本文引用的文献

1
Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.
Expert Rev Anti Infect Ther. 2010 Apr;8(4):419-33. doi: 10.1586/eri.10.19.
2
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
Clin Exp Immunol. 2007 Sep;149(3):440-4. doi: 10.1111/j.1365-2249.2007.03436.x. Epub 2007 Jul 5.
6
Advances in leishmaniasis.
Lancet. 2005;366(9496):1561-77. doi: 10.1016/S0140-6736(05)67629-5.
7
Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis.
Immunol Lett. 2005 Nov 15;101(2):226-30. doi: 10.1016/j.imlet.2005.06.004.
9
Leishmaniasis: current situation and new perspectives.
Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):305-18. doi: 10.1016/j.cimid.2004.03.004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验